Trials / Unknown
UnknownNCT04606511
Lymphedema Screening
Screening for Lymphedema
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Breast cancer-related lymphedema is one of the most common and feared consequences of breast cancer treatment. Currently, there is no established screening program for lymphedema. This cross-sectional study will investigate diagnostic modalities in screening for lymphedema in patients with and without known lymphedema after breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Circumference tape measurements | centimeter and volume criterias |
| DIAGNOSTIC_TEST | Indocyanine green lymphangiography | Presence of dermal backflow |
| DIAGNOSTIC_TEST | bioimpedance spectroscopy | 7.5 and 10 L-DEX criterias |
| DIAGNOSTIC_TEST | Symptom score | using lymph-icf, DASH and SF-36 questionnaires |
Timeline
- Start date
- 2020-10-05
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2020-10-28
- Last updated
- 2021-02-24
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04606511. Inclusion in this directory is not an endorsement.